Boston Children’s and the Broad Institute partner on new center for rare genetic diseases
Three major institutions have launched the Center for Therapeutic Genetics to develop medicines for rare and ultra-rare diseases.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The Broad Institute, Boston Children's Hospital, and The Jackson Laboratory have established the Center for Therapeutic Genetics. This non-profit initiative focuses on the development of genetic medicines specifically for rare and ultra-rare diseases.
Coverage from Yahoo Finance, The Boston Globe, and The New York Times emphasizes the partnership's goal to address diseases that may be considered too rare for traditional development. Precision Medicine Online describes the effort as a New England consortium aimed at scaling gene therapy development.
Future developments will center on the center's ability to scale gene therapy and create treatments for patient populations with rare genetic conditions, as noted by wellcome.org and other reports.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 4h ago.
Quick answers
Which organizations are partnering for this center?
The partnership consists of the Broad Institute, Boston Children's Hospital, and The Jackson Laboratory.
What is the primary purpose of the Center for Therapeutic Genetics?
It is a non-profit effort designed to develop genetic medicines for rare and ultra-rare diseases.
Where is this consortium based?
According to Precision Medicine Online, it is a New England consortium.
Coverage (5)
- Broad Institute, Boston Children's Hospital, and The Jackson Laboratory launch the Center for Therapeutic Genetics, a non-profit effort to develop genetic medicines for rare and ultra-rare diseases Yahoo Finance · 8h ago
- New England Consortium Takes Aim at Scaling Gene Therapy Development Precision Medicine Online · 8h ago
- Gene therapy: changing the future for people with rare diseases wellcome.org · 8h ago
- ‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That The New York Times · 8h ago
- Boston Children’s and the Broad Institute partner on new center for rare genetic diseases The Boston Globe · 8h ago
Topics
Related trends
MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization
MeiraGTx has secured significant new funding from Oberland Capital to advance two gene therapies toward commercialization.
FDA’s top gene therapy regulator is leaving his role
The FDA's top gene therapy regulator is stepping down, amid a significant setback for a kidney disease drug.
Louisiana Notches a Sickle Cell First
A Louisiana man is the first in the state to be functionally cured of sickle cell disease.
Exclusive | FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says
The FDA is reversing its rejection of Regenxbio's gene therapy for Hunter syndrome, marking the third such reversal for rare-disease drugs.
Scientists test first-ever therapy to make human cells young again
Human trials have officially commenced for the first-ever gene therapy designed to rejuvenate human cells and reverse aging.
AI helped diagnose 18 children whose rare diseases had stumped doctors
AI has successfully diagnosed 18 children with rare diseases that had previously baffled medical professionals.